As per the analysis conducted by Market Research Future (MRFR), the Global Viscosupplementation Market is expected to acquire a significant market value of USD 5,243.19 Million while expanding at a CAGR of 10.48% by 2023.
Viscosupplementation is a medical procedure in which a lubricating fluid such as hyaluronan injection or hyaluronic acid (HA) injection is injected into a joint to cure shoulder osteoarthritis, symptoms of hip osteoarthritis, knee osteoarthritis, ankle and spine arthritis.
The rising worldwide prevalence of knee osteoarthritis, the growing demand for minimally invasive procedures, and the increasing geriatric population are some salient factors that can augment the viscosupplementation market size during the forecast period.
On the other hand, stringent government regulations and the rising denials of insurance for viscosupplementation products is likely to hamper the global viscosupplementation market growth during the assessment timeframe.
The outbreak of COVID-19 is expected to create a significant impact on the growth of the viscosupplementation market. The imposition of lockdown for the prevention of COVID-19 is has brought a negative impact on the global viscosupplementation market. However, the key players of the viscosupplementation market are adopting various strategies that can make a significant contribution in uplifting the market in the coming period.
The growing preference for single injection treatment of osteoarthritis is expected to positively impact the market growth in the assessment period. The increasing adoption of a sedentary lifestyle, smoking, and changing lifestyle are some of the other salient causes that are resulting in osteoarthritis and osteoporosis among the expanding population.
Increasing Incidence of Knee Osteoarthritis to Promote the Viscosupplementation Market
Knee osteoarthritis is one of the most common ailments prevalent among the geriatric population. The rising cases of cardiovascular diseases, depression, obesity, renal failure, hypertension, and gastrointestinal bleeding are expected to grow the demand for viscosupplement therapy, thereby augmenting the market during the assessment period.
Integration of Proprietary Technology to Offer Significant Opportunities
The established players of the market are focusing on developing cross-linked hyaluronic acid to provide instant relief from pain. The on-going advancement is expected to offer a significant opportunity to augment the viscosupplementation market share.
Lack of Efficiency to Hamper the Market
The lack of efficiency and the high prices associated with hyaluronic acid treatment are expected to hamper the market growth during the assessment period.
Safety of Products to Pose a Significant Challenge to the Market
The safety concerns associated to the product are likely to pose a significant challenge to the market expansion during the assessment period.
Global Viscosupplementation Market is segmented into Procedure Type, Hyaluronic Acid Type, Application, and End-User.
By Procedure Type
The procedure type based segments of the global viscosupplementation market are single-injection procedure, three-injection procedure, and five-injection procedure. Among all, the three-injection procedure segment is expected to dominate the market due to the lower cost of these products and the shorter treatment regimen in comparison to five-injection procedure products. The single-injection procedure is predicted to acquire the second-largest market, followed by the five-injection procedure for the viscosupplements market. The three-injection procedure is the leading segment, which is likely to grow at the highest CAGR to reach USD 2602.58 million by the end of 2023.
By Hyaluronic Acids
The hyaluronic acid type based segments of the global viscosupplementation market are standard hyaluronic acid and stabilized hyaluronic acid. Between the two segments, the stabilized hyaluronic acid segment is expected to acquire the largest market share owing to the higher quality of the product.
The application-type based segments of the global viscosupplementation market are knee arthritis and hip osteoarthritis. Between the two segments, the knee arthritis segment is expected to account for a larger market share than hip osteoarthritis.
The end-user type based segments of the global viscosupplementation market are hospitals & clinics, and ambulatory surgical centers. Between the two, the hospitals & clinics segment is anticipated to procure a larger market share due to the increasing visit of osteoporosis patients in the hospitals & clinics.
North America to Expand at the Highest CAGR during the Review Period
As per the viscosupplementation market report prepared by MRFR, North America is expected to dominate the global market while expanding at the highest CAGR during the assessment period. The growth of the region can be attributed to the growing demand for minimally invasive viscosupplementation procedures for the treatment of knee osteoarthritis. Furthermore, the presence of advanced healthcare infrastructure established key players, and increasing demand for viscosupplementation products are likely to propel the regional market.
APAC to Value USD 447.24 million by 2023
The Asia-Pacific region is expected to acquire the second-largest market share. APAC is estimated to procure a market value of USD 447.24 million while expanding at a CAGR of 10.48% by 2023. The low-cost manufacturing in India and China is likely to expedite the production facilities that can augment the regional market in the projection timeframe. Furthermore, the increasing initiatives taken by the developing countries to develop their healthcare infrastructure is likely to augment the regional trade during the projection timeframe.
Europe to Expand Owing to Rising Geriatric Population
Europe is anticipated to grow during the forecast period owing to the rising geriatric population. The market in the region is likely to show a significant rise owing to the growing product innovation in the coming period. Among all European countries, the UK is anticipated to make a notable contribution in augmenting the regional market.
MEA to Show Steady Growth during the Assessment Period
MEA is anticipated to show significant growth during the forecast period owing to the growing awareness and the increasing initiatives taken by the countries to develop their healthcare infrastructure.
The market is highly fragmented, and the renowned players are adopting various expansion strategies such as; new product launches, joint ventures, acquisitions, and partnerships. These initiatives are likely to enhance market competition.
Viscosupplementation Market, By Procedure Type
Viscosupplementation Market, By Hyaluronic Acids
Viscosupplementation Market, By Application
Viscosupplementation Market, By End-User
Frequently Asked Questions (FAQ) :
Viscosupplementation is the process of injecting lubricating fluid such as hyaluronic acid into joints to ease the movement of the joint.
The growing prevalence of arthritis is likely to be the major driver for the global viscosupplementation market.
The global viscosupplementation market is expected to rise to a valuation of USD 5.2 billion by 2023.
The global viscosupplementation market is expected to exhibit a solid 8.96% CAGR over the forecast period from 2020 to 2027.
Leading players in the viscosupplementation market include Sanofi, F. Hoffman-La Roche, Zimmer Biomet, Smith & Nephew plc, Ferring BV, and Bioventus, among others.
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.